Donald Trump Diagnosed With Chronic Venous Insufficiency: How Serious Is It And What's the Treatment?
Donald Trump is battling a vein condition called Chronic Venous Insufficiency (CVI), which commonly affects people over 70. Though not life-threatening, it can be quite painful
US President Donald Trump has been diagnosed with a condition known as Chronic Venous Insufficiency (CVI). The disease was detected during a routine medical check-up. According to a statement issued by the White House, the 79-year-old was examined after experiencing swelling and injury in his legs. Doctors later confirmed the presence of CVI. Following the announcement, many have been curious to know more about this condition and its effects on the body.
What is CVI?
As per the Cleveland Clinic, Chronic Venous Insufficiency is a condition where the veins in the legs struggle to send blood back to the heart. Normally, the veins contain small valves that keep blood flowing in the right direction. When these valves become weak or damaged, blood can flow backwards and pool in the legs. This leads to increased pressure in the veins, resulting in swelling, pain, and even ulcers. While not life-threatening, CVI can be extremely uncomfortable and may worsen if left untreated.
How Did Donald Trump Develop This Condition?
Symptoms and Causes of CVI
Early signs of CVI include swelling in the legs or ankles, a feeling of heaviness or fatigue, itching or tingling on the skin, and the appearance of varicose veins. In some cases, the skin may darken, thicken, or become leathery. Open sores or ulcers can also develop. If not addressed in time, these symptoms can become painful and persistent.
The condition usually develops when vein valves are damaged due to previous blood clots or injuries. Ageing naturally weakens the veins, increasing the risk. Other contributing factors include prolonged sitting or standing, obesity, pregnancy, smoking, low physical activity, and a family history of vein disorders.
Treatment
Although CVI cannot be fully cured, its symptoms can be effectively managed. Lifestyle changes like regular walking, elevating the legs, and maintaining a healthy weight can help reduce discomfort. Compression stockings are commonly used to improve blood flow. In addition, doctors may prescribe antibiotics, blood thinners, or medicated wraps. In more severe cases, treatments such as sclerotherapy (injections to close off veins), endovenous ablation, or even surgery may be required. Treatment varies depending on the patient's condition and overall health.
Get breaking news, in-depth analysis, and expert perspectives on everything from geopolitics to diplomacy and global trends. Stay informed with the latest world news only on News18. Download the News18 App to stay updated!
view comments
First Published:
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
an hour ago
- News18
MPESB To Hire For 752 Paramedical Posts, Registration Begins July 28
Last Updated: MPESB Paramedical Recruitment 2025: The detailed information about the vacancies, eligibility criteria, and the application process can be found on The Madhya Pradesh Employees Selection Board (MPESB) has issued a new recruitment notification for 752 paramedical positions under the Group-5 Combined Recruitment Exam (CRE) 2025. The online application process will commence on July 28, 2025, and the deadline to apply is August 11, 2025. The detailed information about the vacancies, eligibility criteria, and the application process can be found on the official website, Age Limit: 18 to 40 years as of January 1, 2025. (Age relaxations are applicable for reserved categories in accordance with MP government norms.) Educational Qualification: Candidates must have a Diploma or Degree in a relevant field (e.g., Pharmacy, OT Technology, Physiotherapy, Optometry, or related paramedical disciplines). Step 5 – Pay the application fee online MPESB Paramedical CRE Recruitment 2025: Selection Process Candidates will be selected through a written examination starting on September 27, 2025. 'In the examination conducted by the Board, names of only those candidates will be included in the list of successful candidates who have secured minimum marks out of the prescribed total marks. For this purpose the minimum qualifying marks shall be 50% for unreserved category candidates and 40% with relaxation of upto 10% for SC, ST, OBC and handicapped candidates," reads the official notice. A 10 per cent relaxation in the minimum qualifying marks has been provided to the candidates of economically weaker sections, but the selection of the candidates will be done on the basis of 'merit' from the list prepared for economically weaker sections. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
News18
an hour ago
- News18
TN CM reviews Ungaludan Stalin public outreach prog from hospital
Chennai, Jul 23 (PTI) Tamil Nadu Chief Minister M K Stalin continued to discharge his official work, from the hospital where he was admitted, for the second consecutive day on Wednesday. He reviewed the conduct of camps for the public outreach programme 'Ungaludan Stalin' (Stain with you) through video conference from the hospital room with Kanyakumari district collector R Alagu Meena, Kancheepuram collector Kalaiselvi Mohan, and Coimbatore collector Pawankumar G Giriyappanavar. During this review, the Chief Minister told them to take appropriate and immediate action on the petitions received from the people at the camps. Later, in a post on the social media platform 'X' Stalin said he reviewed with the officials on whether the camps for Ungaludan Stalin were being held as planned, how many petitions were received from the public till July 22, and the action taken to resolve the petitions. 'I have instructed the Chief Secretary (N Muruganandam) to gather all the details and ensure that there is no delay in resolving the people's problems," the CM said. He was admitted to a hospital here on July 21 due to 'mild giddiness" that he developed during the morning walk. Doctors attending on him advised the Chief Minister rest for three days. PTI JSP ROH Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
News18
an hour ago
- News18
Dr Reddys profit rises marginally to Rs 1,410 cr in Jun qtr
New Delhi, Jul 23 (PTI) Dr Reddy's Laboratories on Wednesday reported a marginal increase in consolidated net profit to Rs 1,410 crore in the June quarter, aided by sustained growth in Europe and India. The Hyderabad-based drug major posted a net profit of Rs 1,392 crore in the year-ago period. Consolidated revenue rose 11 per cent to Rs 8,545 crore in the period under review from Rs 7,673 crore a year earlier. 'We delivered double-digit growth this quarter over the same period last year, reflecting our strength in branded markets and positive momentum in the Nicotine Replacement Therapy portfolio," Dr Reddy's Co-Chairman & MD G V Prasad said. The pricing pressure on Lenalidomide is expected to intensify in the US generics market, he noted. 'We remain focused on strengthening our base business by delivery of our pipeline assets, improving overall productivity and business development," Prasad said. The company noted that growth during the quarter was broad-based, aided by contributions from the acquired consumer healthcare portfolio in nicotine replacement therapy (NRT) and sustained performance in the company's branded markets. In the North American market, its revenue declined by 11 per cent year-on-year to Rs 3,412 crore in the June quarter as compared with Rs 3,846 crore in the year-ago period. The decline was primarily due to increased price erosion in certain key products, including Lenalidomide, it stated. In Europe, the company reported a revenue of Rs 1,274 crore for the first quarter as compared with Rs 526 crore in the year-ago period. The growth in Europe was largely driven by revenues from the acquired NRT portfolio and incremental contributions from new product launches, though partly offset by price erosion, it stated. In India, revenue stood at Rs 1,471 crore against Rs 1,325 crore, a growth of 11 per cent year-on-year. Growth for the quarter was driven by introduction of new products, price increases and commercial execution, Dr Reddy's said. Shares of the company ended 0.58 per cent up at Rs 1,247.55 apiece on the BSE. PTI MSS MSS SHW view comments First Published: July 23, 2025, 18:15 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
